-
![Lenalidomide CAS NO.191732-72-6]()
Lenalidomide CAS NO.191732-72-6Dosage It must be started and provided under the supervision of a doctor with experience in the treatment of multiple myeloma. If the patient's absolute neutrophil count (ANC) <1.0×10 9 /L, or -
![2-Deoxy-2,2-Difluro-D-Erythro-Pentafuranous -1-Ulose-3,5-Dibenzoate(T6) CAS NO.122111-01-7]()
2-Deoxy-2,2-Difluro-D-Erythro-Pentafuranous -1-Ulose-3,5-...MF: C19H14F2O6. MW: 376.31. EINECS: 601-822-8 -
![Cytidine CAS NO.65-46-3]()
Cytidine CAS NO.65-46-3anticancer and antiviral drugs; heterocyclic; pyrimidine nucleotide; heterocyclic block;for CDP-Choline -
![Gefitinib CAS NO. 184475-35-2]()
Gefitinib CAS NO. 184475-35-2Gefitinib Information Gefitinib Chemical Properties Gefitinib Usage -
![Afatinib CAS NO.439081-18-2]()
Afatinib CAS NO.439081-18-2Signal transduction pathway kinase inhibitors; anti-tumor drugs and immunosuppressive agents; small molecule targeted APIs; protein tyrosine kinases -
![Olaparib CAS NO.763113-22-0]()
Olaparib CAS NO.763113-22-0Signal transduction pathway kinase inhibitor; antitumor drugs and immunosuppressive agents; DNA damage -
![Enzalutamide CAS NO.915087-33-1]()
Enzalutamide CAS NO.915087-33-1Heterocyclics; signal transduction pathway kinase inhibitors; androgen receptor antagonists -
![Erlotinib Hydrochloride CAS NO.183319-69-9]()
Erlotinib Hydrochloride CAS NO.183319-69-9Protein tyrosine kinase; small molecule tyrosine kinase inhibitor; signal transduction pathway kinase inhibitor In-house WC EU-GMP -
![Gemcitabine Hydrochloride CAS NO.122111-03-9]()
Gemcitabine Hydrochloride CAS NO.122111-03-9Biologically active small molecules; difluoronucleoside anti-metabolic and anti-tumor drugs BP/EP/USP DMF GMP -
![2-Deoxy-2,2-Difluoro-D-Ribofuranose-3,5-Dibenzoate-1-Methanesulfonate CAS NO.122111-11-9]()
2-Deoxy-2,2-Difluoro-D-Ribofuranose-3,5-Dibenzoate-1-Meth...MF: C20H18F2O8S. MW: 456.41. EINECS: 685-280-8 -
![Gemcitabine Base CAS NO.95058-81-4]()
-
![2-Methyl-4,6-dichloropyrimidine (MDP) CAS NO.1780-26-3]()
2-Methyl-4,6-dichloropyrimidine (MDP) CAS NO.1780-26-3MF: C5H4Cl2N2. MW: 163. EINECS: 605-815-0
Billie Lewis
Todd Nichols
Donna Covington
Bryan Girard
Geneva Gist
Nancy Hand
Lenalidomide | C13H13N3O3 | CID 216326 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities ......
Lenalidomide 10 mg Capsules are a drug that is actively used in oncology. It’s an anticancer drug with immunomodulatory effect. Revlimid is an immunomodulator of a new generation, which not only...
Jan 25, 2022 · commonly reported side effects of lenalidomide include: pneumonia, upper respiratory tract infection, urinary tract infection, neutropenia, thrombocytopenia, abdominal pain, anemia,...
Lenalidomide (Revlimid) Cost in Canada. The cost of 28 capsules of Lenalidomide drug in Canada is between $10, 108- $10, 696. The weight of 28 capsules is 15 mg. Lenalidomide (Revlimid) Cost in...
Lenalidomide is contraindicated in pregnant females and females capable of becoming pregnant. Females of reproductive potential may be treated with lenalidomide provided...
Lenalidomide is used to treat a certain type of myelodysplastic syndrome (a group of conditions in which the bone marrow produces blood cells that are misshapen and does not produce enough healthy...